ROS-Mediated Necrosis by Glycolipid Biosurfactants on Lung, Breast, and Skin Melanoma Cells

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Apr 2

PMID 33796459

Citations 10

Authors

Farazul Haque

Mohd Sajjad Ahmad Khan

Naif Alqurashi

Affiliations

Soon will be listed here.

Abstract

Cancer is one of the major leading causes of death worldwide. Designing the new anticancer drugs is remained a challenging task due to ensure complexicity of cancer etiology and continuosly emerging drug resistance. Glycolipid biosurfactants are known to possess various biological activities including antimicrobial, anticancer and antiviral properties. In the present study, we sought to decipher the mechanism of action of the glycolipids (lactonic-sophorolipd, acidic-sophorolipid, glucolipid, and bolalipid) against cancer cells using lung cancer cell line (A549), breast cancer cell line (MDA-MB 231), and mouse skin melanoma cell line (B16F10). Scratch assay and fluorescence microscopy revealed that glycolipids inhibit tumorous cell migration possibly by inhibiting actin filaments. Fluorescence activated cell sorter (FACS) analysis exhibited that lactonic sophorolipid and glucolipid both induced the reactive oxygen species, altered the mitochondrial membrane potential (ΔΨ) and finally led to the cell death by necrosis. Furthermore, combinatorial effect of lactonic-sophorolipd and glucolipid demonstrated synergistic interaction on A549 cell line whereas additive effect on MDA-MB 231 and B16F10 cell lines. Our study has highlighted that lactonic-sophorolipd and glucolipid could be useful for developing new anticancer drugs either alone or in combination.

Citing Articles

Converging frontiers in cancer treatment: the role of nanomaterials, mesenchymal stem cells, and microbial agents-challenges and limitations.

Afkhami H, Yarahmadi A, Bostani S, Yarian N, Haddad M, Lesani S Discov Oncol. 2024; 15(1):818.

PMID: 39707033 PMC: 11662135. DOI: 10.1007/s12672-024-01590-0.

Unveiling the potential of novel Metschnikowia yeast biosurfactants: triggering oxidative stress for promising antifungal and anticancer activity.

Kumari S, Kumari A, Dhiman A, Mihooliya K, Raje M, Prasad G Microb Cell Fact. 2024; 23(1):245.

PMID: 39261862 PMC: 11389333. DOI: 10.1186/s12934-024-02489-9.

Application of Biosurfactants in Medical Sciences.

Wang X, An J, Cao T, Guo M, Han F Molecules. 2024; 29(11).

PMID: 38893481 PMC: 11173561. DOI: 10.3390/molecules29112606.

Sustainable biosurfactant production from secondary feedstock-recent advances, process optimization and perspectives.

Miao Y, To M, Siddiqui M, Wang H, Lodens S, Chopra S Front Chem. 2024; 12:1327113.

PMID: 38312346 PMC: 10834756. DOI: 10.3389/fchem.2024.1327113.

Harnessing the Potential of Biosurfactants for Biomedical and Pharmaceutical Applications.

Ceresa C, Fracchia L, Sansotera A, De Rienzo M, Banat I Pharmaceutics. 2023; 15(8).

PMID: 37631370 PMC: 10457971. DOI: 10.3390/pharmaceutics15082156.

References

Marostica L, Silva I, Kratz J, Persich L, Geller F, Lang K . Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549. Chem Res Toxicol. 2015; 28(10):1949-60. DOI: 10.1021/acs.chemrestox.5b00153. View

Chen J, Song X, Zhang H, Qu Y, Miao J . Sophorolipid produced from the new yeast strain Wickerhamiella domercqiae induces apoptosis in H7402 human liver cancer cells. Appl Microbiol Biotechnol. 2006; 72(1):52-59. DOI: 10.1007/s00253-005-0243-z. View

Fu S, Wallner S, Bowne W, Hagler M, Zenilman M, Gross R . Sophorolipids and their derivatives are lethal against human pancreatic cancer cells. J Surg Res. 2008; 148(1):77-82. DOI: 10.1016/j.jss.2008.03.005. View

Friedl P, Wolf K . Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003; 3(5):362-74. DOI: 10.1038/nrc1075. View

Yamaguchi H, Condeelis J . Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta. 2006; 1773(5):642-52. PMC: 4266238. DOI: 10.1016/j.bbamcr.2006.07.001. View

Zerbini L, Tamura R, Correa R, Czibere A, Cordeiro J, Bhasin M . Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy. PLoS One. 2011; 6(9):e24285. PMC: 3171406. DOI: 10.1371/journal.pone.0024285. View

Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2011; 127(12):2893-917. DOI: 10.1002/ijc.25516. View

Saerens K, Van Bogaert I, Soetaert W, Vandamme E . Production of glucolipids and specialty fatty acids from sophorolipids by Penicillium decumbens naringinase: Optimization and kinetics. Biotechnol J. 2009; 4(4):517-24. DOI: 10.1002/biot.200800209. View

Ohadi M, Shahravan A, Dehghannoudeh N, Eslaminejad T, Banat I, Dehghannoudeh G . Potential Use of Microbial Surfactant in Microemulsion Drug Delivery System: A Systematic Review. Drug Des Devel Ther. 2020; 14:541-550. PMC: 7008186. DOI: 10.2147/DDDT.S232325. View

10.

Gudina E, Rangarajan V, Sen R, Rodrigues L . Potential therapeutic applications of biosurfactants. Trends Pharmacol Sci. 2013; 34(12):667-75. DOI: 10.1016/j.tips.2013.10.002. View

11.

Haque F, Alfatah M, Ganesan K, Bhattacharyya M . Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth. Sci Rep. 2016; 6:23575. PMC: 4876995. DOI: 10.1038/srep23575. View

12.

Kitamoto D, Isoda H, Nakahara T . Functions and potential applications of glycolipid biosurfactants--from energy-saving materials to gene delivery carriers. J Biosci Bioeng. 2005; 94(3):187-201. DOI: 10.1263/jbb.94.187. View

13.

Muvaffak A, Gurhan I, Gunduz U, Hasirci N . Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate. J Drug Target. 2005; 13(3):151-9. DOI: 10.1080/10611860400029069. View

14.

Liu H, Ma Y, Pagliari L, Perlman H, Yu C, Lin A . TNF-alpha-induced apoptosis of macrophages following inhibition of NF-kappa B: a central role for disruption of mitochondria. J Immunol. 2004; 172(3):1907-15. DOI: 10.4049/jimmunol.172.3.1907. View

15.

Rodrigues L, Teixeira J . Biomedical and therapeutic applications of biosurfactants. Adv Exp Med Biol. 2010; 672:75-87. DOI: 10.1007/978-1-4419-5979-9_6. View

16.

Senderowicz A, Kaur G, Sainz E, Laing C, Inman W, Rodriguez J . Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton. J Natl Cancer Inst. 1995; 87(1):46-51. DOI: 10.1093/jnci/87.1.46. View

17.

Sotirova A, Spasova D, Vasileva-Tonkova E, Galabova D . Effects of rhamnolipid-biosurfactant on cell surface of Pseudomonas aeruginosa. Microbiol Res. 2007; 164(3):297-303. DOI: 10.1016/j.micres.2007.01.005. View

18.

Wu J, Yi W, Jin L, Hu D, Song B . Antiproliferative and cell apoptosis-inducing activities of compounds from Buddleja davidii in Mgc-803 cells. Cell Div. 2012; 7(1):20. PMC: 3538659. DOI: 10.1186/1747-1028-7-20. View

19.

Zhao X, Wakamatsu Y, Shibahara M, Nomura N, Geltinger C, Nakahara T . Mannosylerythritol lipid is a potent inducer of apoptosis and differentiation of mouse melanoma cells in culture. Cancer Res. 1999; 59(2):482-6. View

20.

Cortes-Sanchez A, Hernandez-Sanchez H, Jaramillo-Flores M . Biological activity of glycolipids produced by microorganisms: new trends and possible therapeutic alternatives. Microbiol Res. 2012; 168(1):22-32. DOI: 10.1016/j.micres.2012.07.002. View